Alpha Tau Medical (DRTS) Short-term Investments (2020 - 2026)

Alpha Tau Medical has reported Short-term Investments for 7 years, with the latest figure at $71.8 million in Q1 2026.

• Quarterly Short-term Investments rose 53.98% year-over-year to $71.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71.8 million (up 53.98% YoY) and the FY2025 annual result came in at $60.9 million, up 32.8% from the prior year.
• Short-term Investments advanced to $71.8 million in Q1 2026 per DRTS's latest filing, from $60.9 million in the prior quarter.
• Over five years, Short-term Investments peaked at $8.1 billion in Q1 2022 and troughed at $45.9 million in Q4 2024.
• A 5-year average of $547.1 million and a median of $70.3 million in 2024 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments jumped 1121.46% in 2022, then tumbled 98.78% in 2023.
• Over 5 years, Short-term Investments stood at $98.7 million in 2022, then retreated by 29.95% to $69.1 million in 2023, then plunged by 33.64% to $45.9 million in 2024, then surged by 32.8% to $60.9 million in 2025, then climbed by 17.82% to $71.8 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $71.8 million, $60.9 million, and $68.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.